D. Wallach

R. Figlin, A. Belldegrun, D. Wallach, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Tumor necrosis factor in middle ear effusions.

D. Wallach, A. Schattner, T. Hahn, 1988, Archives of otolaryngology--head & neck surgery.

Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells.

R. Winzen, H. Holtmann, K. Resch, 1992, Journal of immunology.

Hijacking of Host Cell IKK Signalosomes by the Transforming Parasite Theileria

Zhijian J. Chen, S. Rottenberg, V. Heussler, 2002, Science.

Keeping inflammation at bay

D. Wallach, A. Kovalenko, 2014, eLife.

How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-κB activation by members of the TNF/NGF receptor family

D. Wallach, M. Boldin, G. Cantarella, 2002, Arthritis research.

Caspase-8 Is Involved in Neovascularization-Promoting Progenitor Cell Functions

E. Chavakis, T. Kang, A. Zeiher, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Materials and Methods Isolation and Ex Vivo Endothelial Differentiation of Human Endothelial Progenitor Cells

E. Chavakis, T. Kang, A. Zeiher, 2009 .

Activation of the NLRP3 inflammasome by proteins that signal for necroptosis.

T. Kang, Beáta B. Tóth, D. Wallach, 2014, Methods in enzymology.

Nonapoptotic Roles Caspase-8 Serves Both Apoptotic And

T. Kang, A. Waisman, R. Haffner, 2004 .

TRAF2 plays a dual role in NF‐κB‐dependent gene activation by mediating the TNF‐induced activation of p38 MAPK and IκB kinase pathways

W. Fiers, D. Wallach, R. Beyaert, 1998 .

Inhibition by glucocorticosteroid hormones of interferon and prostaglandin E induction by poly(rI). Poly(rC).

I. Maoz, D. Wallach, U. Zor, 1982, The Journal of general virology.

Up the down staircase

D. Wallach, 2002, Nature Immunology.

Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1.

R. Winzen, H. Holtmann, K. Resch, 1993, Journal of immunology.

Proteasome-mediated proteolysis of the interleukin-10 receptor is important for signal downregulation.

Y. Liu, A. Mui, D. Wallach, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Elevated serum levels of soluble tumour necrosis factor receptors (sTNF‐R) in patients with HIV infection

Z. Bentwich, A. Kalinkovich, D. Wallach, 1992, Clinical and experimental immunology.

Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.

H. Holtmann, D. Wallach, 1987, Journal of immunology.

Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells.

D. Wallach, E. Duda, É. Pócsik, 1995, Journal of inflammation.

If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation.

D. Wallach, A. Kovalenko, 2006, Molecular cell.

Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury

D. Wallach, E. Shohami, R. Gallily, 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury.

D. Wallach, E. Shohami, R. Gallily, 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Interferon-induced resistance to the killing by NK cells: a preferential effect of IFN-gamma.

D. Wallach, 1983, Cellular immunology.

Soluble tumor necrosis factor receptors and interleukin‐6 levels in patients with severe preeclampsia

A. Peaceman, D. Wallach, D. Aderka, 1996, Obstetrics and gynecology.

Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS.

D. Wallach, D. Hinton, F. Hofman, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection.

M. Wainberg, Z. Bentwich, A. Kalinkovich, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Variation in serum levels of the soluble TNF receptors among healthy individuals.

D. Wallach, H. Engelmann, D. Aderka, 1992, Lymphokine and cytokine research.

FADD is involved in liver regeneration

P. Galle, A. Lohse, F. Rückert, 2014 .

MORT1/FADD is involved in liver regeneration.

P. Galle, A. Lohse, D. Wallach, 2005, World journal of gastroenterology.

Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.

D. Wallach, T. Hahn, A. Schattner, 1981, Journal of interferon research.

Soluble and cell surface receptors for tumor necrosis factor.

H. Holtmann, D. Wallach, H. Engelmann, 1991, Agents and actions. Supplements.

Involvement of interferon in virus-induced lymphopenia.

A. Meshorer, D. Wallach, A. Schattner, 1983, Cellular immunology.

Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid.

A. Peaceman, D. Wallach, D. Aderka, 1995, American journal of obstetrics and gynecology.

Keeping inflammation at bay Cells dying by apoptosis can trigger an anti-inflammatory gene response in other cells by releasing a compound called adenosine monophosphate.

D. Wallach, A. Kovalenko, 2014 .

Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines.

D. Wallach, Y. Gazitt, A. Schattner, 1984, Clinical immunology and immunopathology.

How do cells sense foreign DNA? A new outlook on the function of STING.

D. Wallach, A. Kovalenko, 2013, Molecular cell.

Suppressive effect of TNF-α and IL-1 on alveolar fibroblast proliferation in sarcoidosis

J. Greif, D. Wallach, E. Fireman, 1992, Mediators of inflammation.

INTRAMUSCULAR HUMAN INTERFERON-β INJECTIONS IN TREATMENT OF CONDYLOMATA ACUMINATA

D. Wallach, J. Shoham, A. Schattner, 1984, The Lancet.

Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor.

D. Wallach, C. Brakebusch, E. Varfolomeev, 1994, The Journal of biological chemistry.

Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects (*)

J. Camonis, I. Mett, D. Wallach, 1995, The Journal of Biological Chemistry.

Screening for proteins that bind to the intracellular domains of the two tumor necrosis factor receptors (TNF-R) revealed effective self-association of the p55 TNF-R “death domain”, which can trigger signaling

J. Camonis, I. Mett, D. Wallach, 1994 .

Cell death induction by TNF: a matter of self control.

D. Wallach, D Wallach, 1997, Trends in biochemical sciences.

Induction of Interleukin-8 Synthesis Integrates Effects on Transcription and mRNA Degradation from at Least Three Different Cytokine- or Stress-Activated Signal Transduction Pathways

Jonathan A. Cooper, R. Winzen, M. Kracht, 1999, Molecular and Cellular Biology.

Increased Serum Levels of Soluble Receptors for Tumor Necrosis Factor in Cancer

D. Wallach, Y. Levo, H. Engelmann, 1991 .

Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons.

D. Wallach, 1986, Interferon.

The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products.

D. Wallach, M. Revel, G. Merlin, 1981, Analytical biochemistry.

High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.

D. Wallach, D. Aderka, Y. Maor, 1996, The Journal of urology.

The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2–p36.3

R. Berger, D. Wallach, D. Chérif, 1991, Human Genetics.

Sensitizing effects and mechanisms of desensitization in regulation of the in vivo response to TNF.

H. Holtmann, D. Wallach, H. Engelmann, 1988, Annales de l'Institut Pasteur. Immunology.

An interferon-induced cellular enzyme is incorporated into virions

D. Wallach, M. Revel, 1980, Nature.

Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies.

J. Weissenbach, M. Perricaudet, H. Soreq, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Increased Serum Levels of Soluble Receptors for Tumor Necrosis Factor in Cancer Patients1

D. Wallach, Y. Levo, D. Aderka, 2006 .

Elevated tumour necrosis factor‐alpha (TNF‐α) biological activity in psoriatic skin lesions

D. Wallach, D. Aderka, M. Greaves, 1994, Clinical and experimental immunology.

Cell death induction by receptors of the TNF family: towards a molecular understanding

P. Vandenabeele, W. Fiers, D. Wallach, 1997, FEBS letters.

Programmed necrosis in inflammation: Toward identification of the effector molecules

D. Green, T. Kang, C. Dillon, 2016, Science.

Concepts of tissue injury and cell death in inflammation: a historical perspective

T. Kang, D. Wallach, A. Kovalenko, 2013, Nature Reviews Immunology.

Enhanced release of lymphotoxins by interferon-treated cells.

D. Wallach, T. Hahn, 1983, Cellular immunology.

Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon.

D. Wallach, D. Aderka, T. Hahn, 1985, Cellular immunology.

Translation of mRNA for human lymphotoxin in microinjected Xenopus oocytes

D. Wallach, T. Hahn, S. Budilovsky, 1984, FEBS letters.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

S. Lipton, A. Ciechanover, T. Luedde, 2018, Cell Death & Differentiation.

Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions.

K. Vuori, D. Wallach, D. Flynn, 2006, Cancer research.

(2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.

D. Wallach, T. Hahn, A. Schattner, 1984, Clinical and experimental immunology.

Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.

D. Wallach, B. Ramot, T. Hahn, 1982, Journal of interferon research.

Site-specific ubiquitination of MLKL targets it to endosomes and targets Listeria and Yersinia to the lysosomes

D. Wallach, K. Bogdanov, Seongmin Yoon, 2022, Cell Death & Differentiation.

Faculty Opinions recommendation of De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

D. Wallach, 2004 .

Roles of TNF and Other Members of the TNF Family in the Regulation of Innate Immunity

D. Wallach, A. Kovalenko, 2016 .

Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome.

Andrew Kovalenko, David Wallach, T. Kang, 2013, Immunity.

Tumor necrosis factor receptor and Fas signaling mechanisms.

Y. Goltsev, D. Wallach, M. Boldin, 1999, Annual review of immunology.

Death-inducing functions of ligands of the tumor necrosis factor family: a Sanhedrin verdict.

D. Wallach, M. Boldin, D Wallach, 1998, Current Opinion in Immunology.

The yeast two-hybrid screening technique and its use in the study of protein-protein interactions in apoptosis.

J. Camonis, I. Mett, D. Wallach, 1998, Current opinion in immunology.

CASH, a Novel Caspase Homologue with Death Effector Domains*

Y. Goltsev, D. Wallach, E. Varfolomeev, 1997, The Journal of Biological Chemistry.

Suicide by order: some open questions about the cell-killing activities of the TNF ligand and receptor families.

D. Wallach, 1996, Cytokine & growth factor reviews.

A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*)

J. Camonis, I. Mett, D. Wallach, 1995, The Journal of Biological Chemistry.

Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity

I. Beletsky, H. Holtmann, D. Wallach, 1994, The Journal of experimental medicine.

RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

T. Kang, D. Wallach, A. Rajput, 2011, Immunity.

D. Wallach, M. Boldin, N. Malinin, 1997, Nature.

The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

G. Courtois, A. Israël, D. Wallach, 2003, Nature.

Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway byCaspase-9

G. Kroemer, R. Flavell, J. Nylandsted, 2006, Molecular and Cellular Biology.

The death domain: a module shared by proteins with diverse cellular functions.

A. Kimchi, E. Feinstein, D. Wallach, 1995, Trends in biochemical sciences.

Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.

D. Wallach, H. Engelmann, Y. Nophar, 1992, The EMBO journal.

Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death

David Wallach, D. Wallach, M. Boldin, 1996, Cell.

Preparations of lymphotoxin induce resistance to their own cytotoxic effect.

D. Wallach, 1984, Journal of immunology.

Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection.

D. Wallach, A. Schattner, M. Revel, 1982, Journal of interferon research.

A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other

D. Wallach, M. Boldin, E. Varfolomeev, 1996, The Journal of experimental medicine.

Tumor necrosis factor receptors of the monocyte derived Langerhans cell phenotype "MoLC".

D. Wallach, B. Czarnetzki, H. Graf, 1995, Advances in experimental medicine and biology.

Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta

D. Wallach, Y. Levo, D. Aderka, 1993 .

The CD95 Receptor: Apoptosis Revisited

M. Peter, J. Desbarats, M. Newell, 2007, Cell.

Hsp90 Recognizes a Common Surface on Client Kinases*

S. Pietrokovski, M. Eisenstein, A. Citri, 2006, Journal of Biological Chemistry.

Functional discrepancies between tumor necrosis factor and lymphotoxin α explained by trimer stability and distinct receptor interactions

A. Porter, D. Wallach, G. Riethmüller, 1995, European journal of immunology.

Programmed Cell Death in Immune Defense: Knowledge and Presumptions.

T. Kang, D. Wallach, 2018, Immunity.

TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein.

R. Alon, K. Yamada, D. Wallach, 1994, Journal of immunology.

Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.

H. Holtmann, D. Wallach, H. Engelmann, 1990, The Journal of biological chemistry.

Mutation of a Self-Processing Site in Caspase-8 Compromises Its Apoptotic but Not Its Nonapoptotic Functions in Bacterial Artificial Chromosome-Transgenic Mice1

T. Kang, B. Ludewig, D. Wallach, 2008, The Journal of Immunology.

Artificial Chromosome-Transgenic Mice Not Its Nonapoptotic Functions in Bacterial Caspase-8 Compromises Its Apoptotic but Mutation of a Self-Processing Site in

T. Kang, B. Ludewig, D. Wallach, 2008 .

Anti‐inflammatory functions of the “apoptotic” caspases

T. Kang, D. Wallach, A. Rajput, 2010, Annals of the New York Academy of Sciences.

A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in ‘reverse signalling’

David Wallach, D. Wallach, G. Chaudhri, 1999, The EMBO journal.

Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants

V. Rotter, M. Oren, P. Krammer, 2003, Oncogene.

Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease

T. Kang, O. Dittrich‐Breiholz, M. Kracht, 2009, The Journal of experimental medicine.

Implications for persistent chlamydial infections of phagocyte-microorganism interplay

E. Manor, D. Wallach, Y. Shemer-Avni, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Identification of viral infections in pregnancy by assay of (2'-5')-oligo-isoadenylate synthetase.

D. Wallach, A. Schattner, A. Schoenfeld, 1985, Early human development.

Soluble cytokine receptors are present in normal human urine

D. Wallach, H. Engelmann, D. Novick, 1989, Journal of Experimental Medicine.

The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

D. Wallach, 2018, Cold Spring Harbor perspectives in biology.

The cybernetics of TNF: Old views and newer ones.

D. Wallach, 2016, Seminars in cell & developmental biology.

12th international TNF conference: the good, the bad and the scientists.

D. Wallach, A. Kovalenko, 2009, Cytokine & growth factor reviews.

Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

A. Cope, D. Lev, D. Wallach, 1998, The Journal of clinical investigation.

Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases

G. Kollias, S. Xanthoulea, H. Lassmann, 2004, The Journal of experimental medicine.

Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells.

H. Holtmann, D. Wallach, Y. Nophar, 1988, Journal of immunology.

The HLA proteins and a related protein of 28 kDa are preferentially induced by interferon‐γ in human WISH cells

D. Wallach, 1983, European journal of immunology.

Extracellular matrix induces tumour necrosis factor-alpha secretion by an interaction between resting rat CD4+ T cells and macrophages.

I. Cohen, S. Miron, D. Wallach, 1993, Immunology.

Aderka, D. et al. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor- or -. Blood 81, 2076−2084

D. Wallach, Y. Levo, H. Engelmann, 1993 .

Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD

P. Galle, A. Waisman, R. Fässler, 2007, The Journal of experimental medicine.

Interferon and lipoid nephrosis.

D. Wallach, A. Schattner, M. Revel, 1988, The American journal of medicine.

I. Mett, D. Wallach, M. Boldin, 1995, FEBS letters.

Up the down staircase

David Wallach, D. Wallach, 2002, Nature Immunology.

Regulation of Cell-Death and Immune Defense by receptors of the TNF/NGF family

T. Kang, D. Wallach, A. Rajput, 2006 .

Inhibition of tumor necrosis factor-induced cell killing by tryptophan and indole.

H. Holtmann, D. Wallach, Y. Yuhas, 1990, European cytokine network.

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.

D. Miles, F. Balkwill, D. Wallach, 1992, British Journal of Cancer.

Cell Surface and Soluble TNF Receptors1

H. Holtmann, D. Wallach, H. Engelmann, 1992 .

Apoptotic cell death in disease—Current understanding of the NCCD 2023

S. Lipton, A. Ciechanover, T. Luedde, 2023, Cell Death & Differentiation.

Recombinant interferon alpha‐C for advanced hairy cell leukemia. An Israeli multicenter study

D. Wallach, Y. Levo, R. Michalevicz, 1988, Cancer.

Reduced production of tumor necrosis factor by mononuclear cells in hairy cell leukemia patients and improvement following interferon therapy

H. Holtmann, D. Wallach, Y. Levo, 1987, Cancer.

The TNF family: only the surface has been scratched.

D. Wallach, 2014, Seminars in immunology.

Long-term protection against the effects of tumour necrosis factor by controlled delivery of the soluble p55 TNF receptor.

J. Kost, D. Wallach, R. Eliaz, 1996, Cytokine.

Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.

E. Kieff, G. Mosialos, T. Gilmore, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN.

H. Holtmann, D. Wallach, T. Hahn, 1986, Immunology letters.

Mechanisms controlling the level of receptors for tumor necrosis factor

R. Winzen, H. Holtmann, K. Resch, 2005, Agents and Actions.

Phosphorylation and dephosphorylation of the RIG-I-like receptors: a safety latch on a fateful pathway.

D. Wallach, A. Kovalenko, 2013, Immunity.

Hormonal protection of interferon‐treated cells against double‐stranded RNA‐induced cytolysis

D. Wallach, M. Revel, 1979, FEBS letters.

Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.

D. Wallach, 1983, The Journal of general virology.

TRAF2 plays a dual role in NF-kappaB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IkappaB kinase pathways.

W. Fiers, D. Wallach, R. Beyaert, 1998, FEBS letters.

The gene for the type 1 tumor necrosis factor receptor (TNF-R1) is localized on band 12p13

R. Berger, D. Wallach, Y. Nophar, 1991, Human Genetics.

A decade of accumulated knowledge and emerging answers. The 6th international congress on TNF Rhodes, Greece. May 1996.

D. Wallach, 1996, European cytokine network.

Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.

A. Cope, M. Feldmann, D. Wallach, 1993, Arthritis and rheumatism.

'Necrosome'-induced inflammation: must cells die for it?

T. Kang, D. Wallach, A. Kovalenko, 2011, Trends in immunology.

Interactions of Tumor Necrosis Factor, Interferon and Interleukin-1 in Cell Killing

H. Holtmann, D. Wallach, S. Israel, 1987 .

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.

D. Wallach, H. Engelmann, David Miles, 1992, British Journal of Cancer.

Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice.

D. Wallach, G. Grau, A. Ythier, 1992, Drug metabolism and disposition: the biological fate of chemicals.

Soluble Tumor Necrosis Factor Receptors in Health and Disease

D. Wallach, H. Engelmann, D. Aderka, 1993 .

Epstein – Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NFk B through a pathway that includes the NFk B-inducing kinase and the I k B kinases IKK a and IKK b

E. Kieff, G. Mosialos, T. Gilmore, 1998 .

Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases

G. Kollias, S. Xanthoulea, H. Lassmann, 2004, The Journal of experimental medicine.

Anti‐inflammatory functions of the “apoptotic” caspases

T. Kang, D. Wallach, A. Rajput, 2010, Annals of the New York Academy of Sciences.